OrbiMed’s Kestra Medical Technologies KMTS Stock Holding History

OrbiMed’s Portfolio KMTS Stock Details KMTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-250,000	Closed	-$6.23M	–	128
2025 Q1	$6.23M	Buy	+250,000	New	+$5.74M	0.15%	75

Other funds holding KMTS

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Yu Fan $108M AUM 137.54% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

OrbiMed's KMTS Position: Q2 2025 in Review

OrbiMed sold out of Kestra Medical Technologies (KMTS) in Q2 2025, closing a stake of 250,000 shares — an estimated $6.23M sold.

OrbiMed first reported a position in KMTS in Q1 2025 and held it in 1 quarter. The position peaked at $6.23M in Q1 2025. 73 funds tracked by Wall St. Rank hold KMTS as of Q2 2025.

OrbiMed reported no remaining Kestra Medical Technologies position as of Q2 2025 after selling out during the quarter.
OrbiMed sold 250,000 Kestra Medical Technologies shares in Q2 2025, an estimated $6.23M.
OrbiMed first reported a position in Kestra Medical Technologies in Q1 2025 and held it in 1 quarter.
OrbiMed's Kestra Medical Technologies position peaked at $6.23M in Q1 2025.
73 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2025.

Based on OrbiMed's 13F filing for Q2 2025, filed 14 Aug 2025.